Aspirin May Cut Pancreatic Cancer Risk
By NICHOLAS BAKALAR, NYT
June 26, 2014 12:05 amJune 26, 2014 7:05 pm
A new study adds to the evidence that low-dose aspirin, known to reduce the risk for heart disease, may also reduce the risk for pancreatic cancer.
Pancreatic cancer has a 93 percent fatality rate, and the National Cancer Institute estimates there will be about 46,000 new cases and 40,000 deaths from the disease this year.
In a five-year study, published online in Cancer Epidemiology, Biomarkers & Prevention, researchers compared aspirin use in 362 pancreatic cancer patients with 690 randomly chosen controls. Participants were asked about past and present regular use of aspirin, defined as at least once a week for three months.
After controlling for age, sex, race, smoking, diabetes and other variables, the researchers found that regular aspirin use lowered the risk for pancreatic cancer by 48 percent.
(More here.)
June 26, 2014 12:05 amJune 26, 2014 7:05 pm
A new study adds to the evidence that low-dose aspirin, known to reduce the risk for heart disease, may also reduce the risk for pancreatic cancer.
Pancreatic cancer has a 93 percent fatality rate, and the National Cancer Institute estimates there will be about 46,000 new cases and 40,000 deaths from the disease this year.
In a five-year study, published online in Cancer Epidemiology, Biomarkers & Prevention, researchers compared aspirin use in 362 pancreatic cancer patients with 690 randomly chosen controls. Participants were asked about past and present regular use of aspirin, defined as at least once a week for three months.
After controlling for age, sex, race, smoking, diabetes and other variables, the researchers found that regular aspirin use lowered the risk for pancreatic cancer by 48 percent.
(More here.)
Powered by Blogger
0 Comments:
Post a Comment
<< Home